GC
COV

Guggenheim Capital’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Guggenheim Capital’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-507,897
Closed -$51.9M – 3154
2014
Q4 		$51.9M Buy
507,897
+20,335
+4% +$1.95M 0.13% 205
2014
Q3 		$42.2M Sell
487,562
-113,424
-19% -$10M 0.1% 278
2014
Q2 		$54.2M Buy
600,986
+237,561
+65% +$17.8M 0.14% 170
2014
Q1 		$26.8M Sell
363,425
-46,013
-11% -$3.21M 0.08% 459
2013
Q4 		$27.9M Buy
409,438
+13,980
+4% +$910K 0.08% 368
2013
Q3 		$24.1M Buy
395,458
+41,409
+12% +$2.53M 0.09% 334
2013
Q2 		$19.7M Buy
+354,049
New +$20.5M 0.08% 343

Guggenheim Capital's COV Position: Q1 2015 in Review

Guggenheim Capital sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 507,897 shares — an estimated $51.9M sold.

Guggenheim Capital first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $54.2M in Q2 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Guggenheim Capital reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Guggenheim Capital sold 507,897 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $51.9M.
  • Guggenheim Capital first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Guggenheim Capital's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $54.2M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Guggenheim Capital's 13F filing for Q1 2015, filed 15 May 2015.